SCHEMBL4958864

SCHEMBL4958864

CCCCC(=O)Nc1ccsc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 1/20 0.60
PTPN2 P17706 2/20 0.55
PTPN1 P18031 2/20 0.55
PTPN6 P29350 1/20 0.52
CDC25B P30305 1/20 0.52
PTPN11 Q06124 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 2/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MAPK8 P45983 3/20 0.49
MAPK10 P53779 3/20 0.49
CETP P11597 1/20 0.49
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPK9 P45984 2/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103381 0.91 ABCC1 (0.63) ABCC1PTPN2PTPN1PTPN6CDC25B
SCHEMBL4959294 0.85 ALDH1A1 (0.63) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL17817419 0.80 ALDH1A1 (0.60) PTPN2PTPN1CDC25BMEN1KMT2A
SCHEMBL14609709 0.79 PTPN2 (0.64) ABCC1PTPN2PTPN1MEN1KMT2A
SCHEMBL28835142 0.78 ABCC1 (0.55) ABCC1PTPN2PTPN1PTPN6CDC25B
SCHEMBL24104683 0.78 MAPK8 (0.62) PTPN2PTPN1CDC25BMEN1KMT2A
SCHEMBL7471912 0.78 TSHR (0.49) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL28804997 0.78 PTPN2 (0.62) ABCC1PTPN2PTPN1MEN1KMT2A
SCHEMBL2255525 0.77 ABCC1 (0.57) ABCC1PTPN2PTPN1MEN1KMT2A
SCHEMBL10037239 0.77 ABCC1 (0.57) ABCC1PTPN2PTPN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed